Patient info Search Menu

Cystitis Relief Tablets – Summary of Product Characteristics (SmPC) for healthcare professionals

Updated:
Key facts
Status:
No longer supplied
Medicine strength:
137.5 mg + 1.735 gram + 1.47 gram

Summary of Product Characteristics (SmPC) - Cystitis Relief tablets

1 NAME OF THE MEDICINAL PRODUCT

Cystitis Relief Tablets

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

Active ingredients mg/tablet

Citric acid 1470

Sodium bicarbonate 1735

Anhydrous sodium carbonate 137.5

3 PHARMACEUTICAL FORM

Effervescent tablet.

4 CLINICAL PARTICULARS

4.1 Therapeutic indications

For the relief of the symptoms of cystitis in women only.

4.2 Posology and method of administration

Adult women: Two tablets to be taken dissolved in water three times a day for 2 days.

Adult men: Not recommended.

Children: Not recommended.

For oral administration.

4.3 Contraindications

Hypertension, cardiovascular disease, renal disease, pregnancy, diabetes and patients on a low sodium diet.

4.4 Special warnings and precautions for use

Medical advice should be sought if symptoms persist after the 2 day course of treatment.

4.5 Interaction with other medicinal products and other forms of interaction

No clinically significant interactions known.

4.6 Pregnancy and lactation

Cystitis Relief Tablets should not be taken during pregnancy.

4.7 Effects on ability to drive and use machines

No adverse effects known.

4.8 Undesirable effects

In view of the short duration of treatment, side effects are unlikely.

4.9 Overdose

In the event of overdosage, symptoms of fluid and electrolyte disturbance may occur.

Treatment need only be symptomatic.

5 PHARMACOLOGICAL PROPERTIES

5.1 Pharmacodynamic properties

Sodium citrate, produced from the reaction between citric acid and sodium bicarbonate, is an alkalinising agent which consequently renders the urine less acidic.

5.2 Pharmacokinetic properties

Sodium citrate is readily absorbed from the gastrointestinal tract and metabolised in the liver to sodium bicarbonate. Less than 5% of the drug is excreted in the urine unchanged.

5.3 Preclinical safety data

There are no preclinical data of relevance to the prescriber which are additional to that already included.

6 PHARMACEUTICAL PARTICULARS

6.1 List of excipients

Saccharin Sodium Ph Eur

Sorbitol Ph Eur

Flay F Pineapple 501085 Firme HSE

Purified Water Ph Eur

Total sodium per tablet is 535mg

6.2 Incompatibilities

None known.

6.3 Shelf life

24 months.

6.4 Special precautions for storage

Not applicable.

6.5 Nature and contents of container

Cold form strip pack containing a nylon/aluminium/polythene laminate and aluminium/polythene laminate.

Pack size: 12

6.6 Special precautions for disposal

Not applicable.

7 MARKETING AUTHORISATION HOLDER

Max Remedies Limited

Stoney Gate House

2 Greenfield Road

Holmfirth

West Yorkshire

HD9 2JT

8 MARKETING AUTHORISATION NUMBER(S)

PL 31308/0024

9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE

AUTHORISATION

17 December 1996

10 DATE OF REVISION OF THE TEXT

11/10/2011

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk)

Last revision stated in the text: 11 October 2011

What the sections and the side effect frequencies mean: How to read a patient leaflet

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Cystitis Relief tablets

What these facts mean

Active substances? Sodium bicarbonate, Sodium carbonate anhydrous, Citric acid
Strength? 137.5 mg + 1.735 gram + 1.47 gram
Pharmaceutical form? Effervescent tablet
How is it taken? Oral
Is it available?? No, all its packs are listed as discontinued (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Drug group (ATC)?
  1. A Alimentary tract and metabolism drugs
    1. A09 Digestives, incl. enzymes
      1. A09A Digestives, incl. enzymes
        1. A09AB Acid preparations, digestives
          1. A09AB04 citric acid
Codes? BNF 07040300

Sources: the NHS Dictionary of Medicines and Devices (dm+d), release 11.1.0 of 9 November 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.